The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIbstock Regulatory News (IBST)

Share Price Information for Ibstock (IBST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 171.60
Bid: 170.40
Ask: 171.40
Change: 0.00 (0.00%)
Spread: 1.00 (0.587%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 171.60
IBST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

13 Aug 2019 15:52

RNS Number : 9124I
Ibstock PLC
13 August 2019
 

13 August 2019

 

Ibstock plc (the "Company")

 

Grant of Awards under the Ibstock plc Long Term Incentive Plan and the Buy-out Agreement

 

Notification of Transactions by Persons Discharging Managerial Responsibility ("PDMRs")

 

The Company announces that it granted an award ("LTIP Award") over Ibstock plc ordinary shares of 1 penny each ("Ordinary Shares") on 12 August 2019 to a PDMR in accordance with the rules of the Ibstock plc Long Term Incentive Plan.

 

Name

Status

Number of Ordinary Shares under LTIP Award

Option Price

Chris McLeish

Chief Financial Officer Designate

170,145

£Nil

 

No consideration was paid for the grant of the LTIP Award which is structured as a nil cost option. The number of Ordinary Shares granted under the LTIP Award has been calculated using an Ordinary Share price of 220.4 pence per share.

 

The normal vesting date of the LTIP Award will be 12 August 2022, being the third anniversary of the award date.

 

Once vested, the LTIP Award will normally be exercisable until the day before the tenth anniversary of the award date.

 

The LTIP Award will normally vest after three years based on the satisfaction of the following performance conditions:-

 

i. 50% on relative TSR against the FTSE 250 construction and building materials companies: median performance (threshold); upper quartile performance (maximum); and

ii. 50% on compound annual Adjusted EPS growth: 6% p.a. compound growth (threshold); 12% p.a. compound growth (maximum).

 

25% of the LTIP Award will vest for threshold performance under both measures, with straight line vesting in between to full vesting for the achievement of maximum performance.

 

A holding period applies, which will commence on vesting of the LTIP Award and end 2 years after vesting.

 

On 12 August 2019 the Company also granted an award ("Buy-out Award") over Ordinary Shares in accordance with the terms of a Buy-out Agreement.

 

Name

Status

Number of Ordinary Shares under Buy-out Award

Option Price

Chris McLeish

Chief Financial Officer Designate

60,393

£Nil

 

The Board agreed to grant the Buy-out Award to compensate, on a fair value basis, the value forgone by Chris McLeish for share awards forfeited on cessation of employment with his previous employer (Tate & Lyle). Mr McLeish's Buy-out Award replaces his awards over Tate & Lyle plc shares for both 2017 and 2018 forfeited as a result of his resignation from Tate & Lyle plc. The fair value of the Buy-out Award has been reduced to take account of the original performance period and the proportion of satisfaction of the performance conditions as at the time of the buy-out. The vesting level will be revisited at the time of vesting to adjust the number of Ibstock shares which vest to reflect the actual vesting of the original Tate & Lyle awards.

 

No consideration was paid for the grant of the Buy-out Award which is structured as a nil cost option. The number of Ordinary Shares granted under the Buy-out Award has been calculated in accordance with the terms of the Buy-out Agreement, based on the value of 18,533 Tate & Lyle shares determined using the Tate & Lyle average closing share price of 754.7 pence measured over the three days prior to 1 August 2019 converted to Ibstock shares using Ibstock's average closing share price of 231.6 pence measured over the three days prior to 1 August 2019, being the date when Chris McLeish commenced employment with Ibstock.

 

The Buy-out Award will normally vest in two instalments on 31 March 2020 and 31 March 2021, in line with the vesting schedule of the original Tate & Lyle plc awards. Once vested, the Buy-out Award will normally be exercisable until the day before the tenth anniversary of the original award dates (1 April 2027 and 1 April 2028 respectively).

 

The level of vesting of the Buy-out Award will be adjusted upwards or downwards as determined by the Remuneration Committee (including, for the avoidance of doubt, to nil) to reflect performance against the targets attached to the original awards.

 

The information below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Chris McLeish

2

 

Reason for the notification

a)

Position/status

Chief Financial Officer Designate

b)

Initial notification/Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ibstock plc

b)

LEI

2138003QHTNX34CN9V93

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1p each

Identification code

GB00BYXJC278

b)

 

Nature of the transaction

Grant of awards under (a) the Ibstock plc Long Term Incentive Plan and (b) the Buy-out Agreement

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

(a)

Nil

170,145

(b)

Nil

60,393

d)

 

Aggregated information

- Aggregated volume

230,538

- Price

Nil

e)

Date of the transaction

2019-08-12

f)

Place of the transaction

Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDMGMRDFLGLZM
Date   Source Headline
1st Oct 202112:50 pmRNSTotal Voting Rights and Share Capital
1st Sep 202111:00 amRNSTotal Voting Rights and Share Capital
4th Aug 20217:00 amRNSInterim Results
16th Jul 202112:34 pmRNSBlock listing Interim Review
1st Jul 20215:00 pmRNSTotal Voting Rights
30th Jun 20213:30 pmRNSReport on Payments to Govts
30th Jun 20219:33 amRNSHolding(s) in Company
25th Jun 20217:00 amRNSHolding(s) in Company
22nd Apr 202112:00 pmRNSAnnual General Meeting 2021 Results
22nd Apr 20217:00 amRNSAGM Trading Update & Strategic Growth Investment
15th Apr 20214:30 pmRNSDirector/PDMR Shareholding
12th Apr 20214:34 pmRNSNotification of Trading Statement
8th Apr 202111:00 amRNSTotal Voting Rights and Share Capital
26th Mar 202110:00 amRNSDirector/PDMR Shareholding
22nd Mar 20212:33 pmRNSAnnual Financial Report
10th Mar 20217:00 amRNSPreliminary Results
2nd Feb 20212:34 pmRNSBlock Listing Six Monthly Return
2nd Feb 20219:58 amRNSHolding(s) in Company
21st Jan 20217:00 amRNSTrading Update
2nd Nov 20204:20 pmRNSDirector/PDMR Shareholding
28th Oct 20207:00 amRNSTrading Update
19th Oct 202012:12 pmRNSNotification of Trading Update
8th Oct 20207:00 amRNSAppointment of Joint Corporate Broker
3rd Sep 20204:16 pmRNSHolding(s) in Company
14th Aug 20209:43 amRNSHolding(s) in Company
6th Aug 20207:00 amRNSInterim Results
29th Jul 20203:17 pmRNSBlock Listing Six Monthly Return
24th Jul 202010:00 amRNSDirectorate Change
8th Jul 202012:30 pmRNSNotification of Half Year Results
3rd Jun 20207:00 amRNSTrading Update
1st Jun 20203:35 pmRNSTotal Voting Rights and Share Capital
21st May 20204:49 pmRNSAnnual General Meeting 2020 Results
15th May 20204:12 pmRNSCOVID-19 and AGM Update
15th Apr 20205:49 pmRNSDirector/PDMR Shareholding
8th Apr 20205:36 pmRNSHolding(s) in Company
6th Apr 20202:35 pmRNSAnnual Report and Update on COVID-19 Response
1st Apr 20204:17 pmRNSDirector/PDMR Shareholding
30th Mar 202012:45 pmRNSHolding(s) in Company
24th Mar 20205:41 pmRNSCOVID-19 Update
20th Mar 20202:42 pmRNSHolding(s) in Company
18th Mar 202012:08 pmRNSHolding(s) in Company
11th Mar 20207:00 amRNSDirector/PDMR Shareholding
4th Mar 20204:59 pmRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSPreliminary Results
19th Feb 202011:26 amRNSStandard form for notification of major holdings
4th Feb 20203:34 pmRNSStandard Form for Notification of Major Holdings
28th Jan 202011:14 amRNSHolding(s) in Company
22nd Jan 20205:48 pmRNSStandard Form for Notification of Major Holdings
20th Jan 20203:18 pmRNSBlock Listing Six Monthly Return
16th Jan 20207:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.